1

Mini-antibodies Reactivate the p53 protein: The Promising Pathway for Tumor Therapy

News Discuss 
A critical advance in cancer study is arising with the use of nanobodies to re-engage dysfunctional p53. This crucial malignant protector protein is frequently inactivated in several kinds of tumors, causing https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research

Comments

    No HTML

    HTML is disabled


Who Upvoted this Story